The effect of fetal hemoglobin level on pregnant Saudi Arabs with sickle cell disease

被引:3
作者
Ekuma-Nkama, EN [1 ]
机构
[1] Saudi Aramco Med Serv Org, Al Hasa Specialty Med Serv Div, Mubarraz, Saudi Arabia
关键词
sickle cell disease; fetal hemoglobin; pregnancy;
D O I
10.1016/S0020-7292(97)00220-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:65 / 66
页数:2
相关论文
共 50 条
  • [21] Effect of Hydroxyurea in Children With Sickle Cell Disease in Saudi Arabia
    Al Hawsawi, Zakaria Mohammed
    Turkistani, Waheed Ahmed
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2008, 3 (02): : 129 - 134
  • [22] Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes
    Ikuta, Tohru
    Sellak, Hassan
    Liu, Si-Yang
    Odo, Nadine
    JOURNAL OF BLOOD MEDICINE, 2018, 9 : 95 - 104
  • [23] Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania
    Nkya, Siana
    Mwita, Liberata
    Mgaya, Josephine
    Kumburu, Happiness
    van Zwetselaar, Marco
    Menzel, Stephan
    Mazandu, Gaston Kuzamunu
    Sangeda, Raphael
    Chimusa, Emile
    Makani, Julie
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [24] A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease
    Pule, Gift D.
    Mowla, Shaheen
    Novitzky, Nicolas
    Wiysonge, Charles S.
    Wonkam, Ambroise
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 669 - 679
  • [25] Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease
    Pace, Betty S.
    Liu, Li
    Li, Biaoru
    Makala, Levi H.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (08) : 1050 - 1064
  • [26] Phenotypic variation in sickle cell disease: the role of beta globin haplotype, alpha thalassemia, and fetal hemoglobin in HbSS
    Serjeant, Graham R.
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (02) : 107 - 116
  • [27] Fetal hemoglobin gene expression in patients with sickle cell disease in North Central Nigeria
    Dangana, Amos
    Nasir, Idris Abdullahi
    Medugu, Jessy Thomas
    Emelike, Felix O.
    Oluwatayo, B. O.
    Haruna, Abubakar Shehu
    INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES, 2018, 7 (02) : 98 - 103
  • [28] In Vitro Characterization of FTX6058, a Novel Small Molecule Fetal Hemoglobin Inducer for Sickle Cell Disease
    Stuart, Billy
    Rahl, Peter
    Appiah, Kingsley
    Efremov, Ivan
    Thompson, Lorin
    Wallace, Owen
    Moxham, Christopher
    BLOOD, 2020, 136
  • [29] Benefits of Delayed Fetal Hemoglobin (HbF) Switching in Sickle Cell Disease (SCD): A Case Report and Review of the Literature
    Pack-Mabien, Ardie V.
    Imran, Hamayun
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (08) : E347 - E349
  • [30] SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon
    Pule G.D.
    Bitoungui V.J.N.
    Chemegni B.C.
    Kengne A.P.
    Wonkam A.
    BMC Research Notes, 10 (1)